title: No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
abstract: The X-ray repair cross-complementing group 1 (XRCC1) gene belongs to the family of DNA repair genes. Polymorphisms in the XRCC1 gene, Arg399Gln, Arg194Trp and Arg280His, have been reported to have implications in differentiated thyroid carcinoma (DTC) susceptibility, but the results remain conflicting and no meta-analysis has been published. Therefore, we carried out a systematic review of the published epidemiology studies, aiming to assess the relationship between XRCC1 polymorphisms and susceptibility to DTC risk. We selected three databases, PubMed, EMBASE and CNKI, in which to search for published literature. With respect to DTC risk associated with XRCC1, combined odds ratios (ORs) and 95% confidence intervals (CI) were appropriately calculated on the basis of co-dominant, dominant and recessive models. To investigate different effects from specific race, subgroup analyses were carried out in Asian and Caucasian populations. Eight studies meeting the inclusion criteria were eventually selected for Arg399Gln (1,550 cases and 2,692 controls), five studies for Arg194Trp (858 cases and 1,394 controls) and five studies for Arg280His (1,237 cases and 2,267 controls). The combined results of the relevant studies exhibited that no significant associations with DTC risk were demonstrated for polymorphisms in XRCC1 Arg399Gln, Arg194Trp and Arg280His in all genetic models. Stratified analyses in Asian and Caucasian populations showed similar results. This meta-analysis arrives at a conclusion that the XRCC1 (Arg399Gln, Arg194Trp, Arg280His) polymorphisms appear to confer no risk for DTC.
authors.affiliation: School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
authors.forename: Cuiping
authors.initials: C
authors.lastname: Li
authors.forename: Xue
authors.initials: X
authors.lastname: Xiang
authors.forename: Yang
authors.initials: Y
authors.lastname: Zhou
mesh_terms: D004268:DNA-Binding Proteins / Q000235:genetics*; D006801:Humans; D016017:Odds Ratio; D011110:Polymorphism, Genetic / Q000235:genetics*; D012044:Regression Analysis; D013964:Thyroid Neoplasms / Q000235:genetics*; D000076105:X-ray Repair Cross Complementing Protein 1
chemical_list: D004268:DNA-Binding Proteins; D000076105:X-ray Repair Cross Complementing Protein 1; C000619371:XRCC1 protein, human
references.citation: Oncol Rep. 2012 Nov;28(5):1859-68
references.pmid: 22922830
references.citation: J Endocrinol Invest. 2008 Oct;31(10):893-9
references.pmid: 19092295
references.citation: Cancer. 2004 Sep 15;101(6):1463-72
references.pmid: 15368334
references.citation: Carcinogenesis. 2000 May;21(5):965-71
references.pmid: 10783319
references.citation: Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):465-8
references.pmid: 9641488
references.citation: Nature. 2001 May 17;411(6835):366-74
references.pmid: 11357144
references.citation: Hell J Nucl Med. 2009 Sep-Dec;12(3):266-70
references.pmid: 19936341
references.citation: Control Clin Trials. 1986 Sep;7(3):177-88
references.pmid: 3802833
references.citation: Ann Intern Med. 1997 Nov 1;127(9):820-6
references.pmid: 9382404
references.citation: Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):702-5
references.pmid: 15555397
references.citation: Prostate Cancer Prostatic Dis. 2011 Sep;14(3):225-31
references.pmid: 21647176
references.citation: EMBO J. 2001 Nov 15;20(22):6530-9
references.pmid: 11707423
references.citation: JAMA. 1989 Dec 15;262(23):3313-5
references.pmid: 2479781
references.citation: Science. 2001 Feb 16;291(5507):1284-9
references.pmid: 11181991
references.citation: Cancer Causes Control. 2003 Oct;14(8):787-9
references.pmid: 14674743
references.citation: Biometrics. 1994 Dec;50(4):1088-101
references.pmid: 7786990
references.citation: Cancer Lett. 2009 Nov 28;285(2):134-40
references.pmid: 19481337
references.citation: Mutat Res. 2011 May 10;709-710:67-72
references.pmid: 21414327
references.citation: Mutat Res. 2013 Jan 20;750(1-2):34-9
references.pmid: 23022340
references.citation: EMBO J. 2008 Dec 3;27(23):3140-50
references.pmid: 18971944
references.citation: Breast Cancer Res. 2005;7(6):R1168-73
references.pmid: 16457697
references.citation: Nat Genet. 2001 Nov;29(3):306-9
references.pmid: 11600885
references.citation: J Korean Med Sci. 2011 Aug;26(8):991-5
references.pmid: 21860547
references.citation: Cancer Res. 1999 Jun 1;59(11):2557-61
references.pmid: 10363972
references.citation: Cancer Lett. 2000 Oct 16;159(1):63-71
references.pmid: 10974407
references.citation: BMJ. 1997 Sep 13;315(7109):629-34
references.pmid: 9310563
references.citation: Int J Cancer. 2009 Sep 1;125(5):1102-9
references.pmid: 19444915
references.citation: Clin Cancer Res. 2008 Sep 15;14(18):5919-24
references.pmid: 18779313
references.citation: Breast Cancer Res Treat. 2009 May;115(1):137-44
references.pmid: 18481169
references.citation: Endocr Relat Cancer. 2009 Jun;16(2):491-503
references.pmid: 19286843
references.citation: EMBO J. 1998 Nov 2;17(21):6404-11
references.pmid: 9799248
references.citation: Carcinogenesis. 2000 Jul;21(7):1329-34
references.pmid: 10874010
references.citation: Nucleic Acids Res. 2004 Apr 23;32(7):2193-201
references.pmid: 15107487
references.citation: Nicotine Tob Res. 2004 Apr;6(2):381-2
references.pmid: 15203812
references.citation: Clin Cancer Res. 1998 Jul;4(7):1773-8
references.pmid: 9676854
references.citation: Iran Biomed J. 2011;15(3):73-8
references.pmid: 21987112
references.citation: EMBO J. 1996 Dec 2;15(23):6662-70
references.pmid: 8978692
references.citation: Int J Cancer. 2000 Nov 15;88(4):601-6
references.pmid: 11058877
references.citation: Leuk Lymphoma. 2013 Jan;54(1):153-9
references.pmid: 22712837
references.citation: Thyroid. 2009 Feb;19(2):129-35
references.pmid: 19191745
references.citation: Int J Cancer. 2004 Sep 20;111(5):805-8
references.pmid: 15252855
references.citation: Cancer Res. 1989 Aug 15;49(16):4626-8
references.pmid: 2472882
references.citation: Int J Epidemiol. 1999 Feb;28(1):1-9
references.pmid: 10195657
references.citation: BMJ. 2003 Sep 6;327(7414):557-60
references.pmid: 12958120